• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Toward understanding the 2019 Coronavirus and its impact on the heart.

作者信息

Becker Richard C

机构信息

, Cincinnati, USA.

出版信息

J Thromb Thrombolysis. 2020 Jul;50(1):33-42. doi: 10.1007/s11239-020-02107-6.

DOI:10.1007/s11239-020-02107-6
PMID:32297133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7156795/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febc/7156795/f3d2f8e80051/11239_2020_2107_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febc/7156795/31c256aa0f00/11239_2020_2107_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febc/7156795/aad2999ecb31/11239_2020_2107_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febc/7156795/f3d2f8e80051/11239_2020_2107_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febc/7156795/31c256aa0f00/11239_2020_2107_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febc/7156795/aad2999ecb31/11239_2020_2107_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febc/7156795/f3d2f8e80051/11239_2020_2107_Fig3_HTML.jpg

相似文献

1
Toward understanding the 2019 Coronavirus and its impact on the heart.迈向了解2019冠状病毒及其对心脏的影响。
J Thromb Thrombolysis. 2020 Jul;50(1):33-42. doi: 10.1007/s11239-020-02107-6.
2
The Novel Coronavirus 2019 epidemic and kidneys.2019新型冠状病毒疫情与肾脏
Kidney Int. 2020 May;97(5):824-828. doi: 10.1016/j.kint.2020.03.001. Epub 2020 Mar 7.
3
Hypotension, Systemic Inflammatory Response Syndrome, and COVID-19: A Clinical Conundrum.低血压、全身炎症反应综合征与新型冠状病毒肺炎：一个临床难题。
Anesth Analg. 2020 Sep;131(3):e175-e176. doi: 10.1213/ANE.0000000000005062.
4
We all need a yellow submarine!我们都需要一艘黄色潜水艇！
Prog Cardiovasc Dis. 2020 May-Jun;63(3):389. doi: 10.1016/j.pcad.2020.04.001. Epub 2020 Apr 1.
5
The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities.新型冠状病毒病 2019（COVID-19）的心肺病理学：来自德克萨斯州休斯顿的 3 例尸检报告，并回顾了美国其他城市的尸检结果。
Cardiovasc Pathol. 2020 Sep-Oct;48:107233. doi: 10.1016/j.carpath.2020.107233. Epub 2020 May 7.
6
Coronavirus disease 2019 outbreak.2019年冠状病毒病疫情
Panminerva Med. 2020 Jun;62(2):73-74. doi: 10.23736/S0031-0808.20.03897-5. Epub 2020 Mar 23.
7
COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.新型冠状病毒肺炎凝血功能障碍与炎症：已知与未知
Anesth Analg. 2020 Nov;131(5):1323. doi: 10.1213/ANE.0000000000005215.
8
Forced Choices: Ethical Challenges in Cardiology During the COVID-19 Pandemic.强制选择：新冠疫情期间心脏病学面临的伦理挑战
Circulation. 2020 Jul 21;142(3):194-196. doi: 10.1161/CIRCULATIONAHA.120.047681. Epub 2020 May 11.
9
[What I talk about when I talk about COVID-19].当我谈论新冠病毒时我在谈些什么
Laeknabladid. 2020 Sep;106(9):395. doi: 10.17992/lbl.2020.09.594.
10
Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19.新型冠状病毒肺炎患者心脏受累的临床特征及危险因素。
J Am Heart Assoc. 2020 Sep 15;9(18):e016807. doi: 10.1161/JAHA.120.016807. Epub 2020 Aug 18.

引用本文的文献

1
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.新型冠状病毒肺炎血栓形成：区分病理、机制、表型特征及管理
J Thromb Thrombolysis. 2025 Jan;58(1):15-49. doi: 10.1007/s11239-024-03028-4. Epub 2024 Aug 23.
2
Cardiovascular diseases as risk factors of post-COVID syndrome: a systematic review.心血管疾病作为新冠后综合征的危险因素：一项系统评价。
BMC Public Health. 2024 Jul 10;24(1):1846. doi: 10.1186/s12889-024-19300-4.
3
Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究：中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
3
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?
新型冠状病毒肺炎中的凝血与炎症：炎症标志物与凝血标志物之间的相互关系。
Ann Hematol. 2024 Jun;103(6):1819-1831. doi: 10.1007/s00277-024-05630-1. Epub 2024 Feb 13.
4
Effects of COVID-19 on the Autonomic Cardiovascular System: Heart Rate Variability and Turbulence in Recovered Patients.新型冠状病毒肺炎对自主心血管系统的影响：恢复期患者的心率变异性和血流动力学不稳定性。
Tex Heart Inst J. 2023 Aug 21;50(4). doi: 10.14503/THIJ-22-7952.
5
Evaluating chest pain in patients with post COVID conditions permission to think outside of the box.评估新冠后(post COVID)条件下胸痛患者 需跳出固有思维。
J Thromb Thrombolysis. 2023 May;55(4):592-603. doi: 10.1007/s11239-023-02808-8. Epub 2023 Apr 13.
6
Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism.靶向基因分析揭示 ACE I/D 和 APO T158C 多态性与伴有肺栓塞的重症 COVID-19 患者 D-二聚体水平之间的新关联。
J Thromb Thrombolysis. 2023 Jan;55(1):51-59. doi: 10.1007/s11239-022-02728-z. Epub 2022 Nov 13.
7
Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems.长新冠综合征与心血管系统：多系统神经心效应综述。
Curr Cardiol Rep. 2022 Nov;24(11):1711-1726. doi: 10.1007/s11886-022-01786-2. Epub 2022 Sep 30.
8
Induction of homeostatic biological parameters in reward deficiency as a function of an iron-free multi-nutrient complex: Promoting hemoglobinization, aerobic metabolism, viral immuno-competence, and neuroinflammatory regulation.作为一种无铁多种营养素复合物的作用，在奖励缺乏中诱导稳态生物学参数：促进血红蛋白化、有氧代谢、病毒免疫能力和神经炎症调节。
J Syst Integr Neurosci. 2020 Jun 29;7. doi: 10.15761/JSIN.1000234.
9
Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.新型冠状病毒肺炎患者的全身炎症可能会引发各种类型的静脉和动脉血栓形成：系统评价。
Scand J Immunol. 2021 Nov;94(5):e13097. doi: 10.1111/sji.13097. Epub 2021 Sep 27.
10
Effect evaluation of non-pharmaceutical interventions taken in China to contain the COVID-19 epidemic based on the susceptible-exposed-infected-recovered model.基于易感-暴露-感染-康复模型对中国采取的遏制新冠疫情非药物干预措施的效果评估
Technol Forecast Soc Change. 2021 Oct;171:120987. doi: 10.1016/j.techfore.2021.120987. Epub 2021 Jun 23.
新型冠状病毒肺炎与血管紧张素转换酶抑制剂及血管紧张素受体阻滞剂：证据是什么？
JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812.
4
Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China.中国湖北 2019 年冠状病毒病患儿的临床特征。
Curr Med Sci. 2020 Apr;40(2):275-280. doi: 10.1007/s11596-020-2172-6. Epub 2020 Mar 24.
5
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.单细胞 RNA 测序分析 13 个人体组织样本，鉴定出人类冠状病毒的细胞类型和受体。
Biochem Biophys Res Commun. 2020 May 21;526(1):135-140. doi: 10.1016/j.bbrc.2020.03.044. Epub 2020 Mar 19.
6
Insight into COVID-2019 for pediatricians.儿科医生对 COVID-2019 的认识。
Pediatr Pulmonol. 2020 May;55(5):E1-E4. doi: 10.1002/ppul.24734. Epub 2020 Mar 18.
7
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
8
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.2019年冠状病毒病（COVID-19）疫情对中国香港ST段抬高型心肌梗死治疗的影响
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. Epub 2020 Mar 17.
9
Epidemiology of COVID-19 Among Children in China.中国儿童 COVID-19 流行病学。
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2020-0702. Epub 2020 Mar 16.
10
Clinical features of deaths in the novel coronavirus epidemic in China.中国新型冠状病毒疫情死亡患者的临床特征。
Rev Med Virol. 2020 May;30(3):e2103. doi: 10.1002/rmv.2103. Epub 2020 Mar 16.